Načítá se...
MG-132 Inhibits Carcinoid Growth and Alters the Neuroendocrine Phenotype
BACKGROUND: Carcinoid cancers are the most common neuroendocrine (NE) tumors and limited treatment options exist. The inhibition of Glycogen Synthase Kinase-3β (GSK-3β) has been shown to be a potential therapeutic target to the treatment of carcinoid disease. In this study we investigate the ability...
Uloženo v:
| Hlavní autoři: | , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2010
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2795050/ https://ncbi.nlm.nih.gov/pubmed/19765735 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jss.2009.05.032 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|